Hypercholesterolemia — Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Citation(s)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Apolipoprotein B(ApoB) Reduction by ISIS 301012 on Liver Triglyceride Content in Subjects With Varying Degrees of Hyperlipidemia